Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation
Edgar Grinstein1, Ying Shan2, Leonid Karawajew3
1Institute of Transplantation Diagnostics and Cellular Therapeutics, Heinrich Heine University Medical Center, 40225 Düsseldorf, Germany.
Abstract:
Retinoblastoma protein (Rb) is a multifunctional tumor suppressor, frequently inactivated in certain types of human cancer. Nucleolin is an abundant multifunctional phosphoprotein of proliferating and cancerous cells, recently identified as cell cycle-regulated transcription activator, controlling expression of human papillomavirus type 18 (HPV18) oncogenes in cervical cancer. Here we find that nucleolin is associated with Rb in intact cells in the G1 phase of the cell cycle, and the complex formation is mediated by the growth-inhibitory domain of Rb. Association with Rb inhibits the DNA binding function of nucleolin and in consequence the interaction of nucleolin with the HPV18 enhancer, resulting in Rb-mediated repression of the HPV18 oncogenes. The intracellular distribution of nucleolin in epithelial cells is Rb-dependent, and an altered nucleolin localization in human cancerous tissues results from a loss of Rb. Our findings suggest that deregulated nucleolin activity due to a loss of Rb contributes to tumor development in malignant diseases, thus providing further insights into the molecular network for the Rb-mediated tumor suppression.
Insights
Retinoblastoma protein (Rb) suppresses tumors by binding nucleolin, inhibiting human papillomavirus oncogenes. Loss of Rb disrupts this, allowing nucleolin to promote cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Retinoblastoma protein (Rb) is a key tumor suppressor often lost in cancers.
- Nucleolin, a phosphoprotein in proliferating cells, activates human papillomavirus type 18 (HPV18) oncogenes in cervical cancer.
Purpose of the Study:
- To investigate the interaction between Retinoblastoma protein (Rb) and nucleolin.
- To elucidate the role of this interaction in the regulation of HPV18 oncogenes and tumor suppression.
Main Methods:
- Cell cycle analysis in G1 phase.
- Co-immunoprecipitation to detect protein-protein interactions.
- Analysis of DNA binding and gene expression.
Main Results:
- Nucleolin associates with Rb in G1 phase cells, mediated by Rb's growth-inhibitory domain.
- Rb binding inhibits nucleolin's DNA binding and interaction with the HPV18 enhancer.
- Rb loss leads to altered nucleolin localization and contributes to tumor development.
Conclusions:
- Rb-mediated inhibition of nucleolin's oncogenic activity is a critical tumor suppressive mechanism.
- Disruption of the Rb-nucleolin interaction due to Rb loss promotes malignant disease progression.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules

